Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 26, 2026

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

Xoft Axxent electronic brachytherapy.

Adam Dickler1, Kambiz Dowlatshahi

  • 1Department of Radiation Oncology, Little Company of Mary Hospital, 2800 West 95th Street, Evergreen Park, IL 60805, USA. atd22_99@yahoo.com

Expert Review of Medical Devices
|December 25, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis.

OncoTargets and therapy·2011
Same author

Surgical perspectives from a prospective, nonrandomized, multicenter study of breast conserving surgery and adjuvant electronic brachytherapy for the treatment of breast cancer.

World journal of surgical oncology·2011
Same author

Twelve-month follow-up results of a trial utilizing Axxent electronic brachytherapy to deliver intraoperative radiation therapy for early-stage breast cancer.

Annals of surgical oncology·2010
Same author

Prospective multi-center trial utilizing electronic brachytherapy for the treatment of endometrial cancer.

Radiation oncology (London, England)·2010
Same author

Experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation.

American journal of clinical oncology·2010
Same author

Tomotherapy and multifield intensity-modulated radiotherapy planning reduce cardiac doses in left-sided breast cancer patients with unfavorable cardiac anatomy.

International journal of radiation oncology, biology, physics·2009
Same journal

Review of regulatory requirements for benefit - risk assessment for medical devices: uncovering existing methodologies.

Expert review of medical devices·2026
Same journal

Two sides to every wrist: trans-ulnar access for cardiac interventions.

Expert review of medical devices·2026
Same journal

Comparative review of coronary CT angiography versus conventional catheter angiography: diagnostic value, clinical outcomes, and underlying technical principles.

Expert review of medical devices·2026
Same journal

Assessing the MYNX CONTROL arterial vascular closure device after catheterization procedures that enter the body through the femoral arteries.

Expert review of medical devices·2026
Same journal

Efficacy of two anatomically preformed supraglottic devices, the BlockBuster Laryngeal mask airway and the Ambu AuraGain, for ventilation in anesthetised paralyzed pediatric patients: a randomized trial.

Expert review of medical devices·2026
Same journal

Prismatic treatment combined with binocular visual training for intermittent exotropia: impact on visual function and quality of life.

Expert review of medical devices·2026
See all related articles

Xoft Axxent electronic brachytherapy (eBX) offers a more accessible approach to accelerated partial-breast irradiation for breast cancer patients. This novel method uses an electronic source, potentially benefiting more patients with reduced radiation to normal tissues.

Area of Science:

  • Oncology
  • Medical Physics
  • Radiotherapy

Background:

  • Balloon-based brachytherapy aims to improve access to accelerated partial-breast irradiation (APBI).
  • Traditional APBI methods may have limitations in accessibility and require specialized equipment.

Purpose of the Study:

  • To introduce Xoft Axxent electronic brachytherapy (eBX) as a novel APBI method.
  • To highlight the advantages of eBX over existing brachytherapy devices.

Main Methods:

  • Utilizes an electronic source to generate x-rays for brachytherapy.
  • Does not require a high dose rate afterloader unit or a shielded vault.

Main Results:

  • eBX may increase patient accessibility to APBI.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

Related Experiment Videos

Last Updated: Jun 26, 2026

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

  • Demonstrates a lower radiation dose to normal tissues compared to the MammoSite device.
  • Achieves larger 'hot spots' indicating precise radiation delivery.
  • Conclusions:

    • eBX presents a potentially more accessible and effective option for APBI.
    • The technology shows promise for broader patient application in breast cancer treatment.
    • Further applications, such as endometrial cancer treatment, are under development.